title: Flow cytometric evaluation of cell cycle regulators (cyclins and cyclin-dependent kinase inhibitors) expressed on bone marrow cells in patients with chronic myeloid leukemia and multiple myeloma.
abstract: OBJECTIVE
  The aim of this study was to use flow cytometry to analyze the expression of cell cycle-regulating elementswith low and high proliferative signatures in patients with malignant diseases.
  
  
  METHODS
  Cyclin D, E, A, and B, and cyclin-dependent kinase inhibitor (CDKI) p16 and p21 levels weremeasured via flow cytometry in patients with chronic myeloid leukemia (CML) (n = 16) and multiple myeloma (MM)(n = 13), and in controls (n = 15).
  
  
  RESULTS
  The distributions of the cell cycle S phase were 10, 63%, 6, 72% and 3, 59%; for CML, MM and controlpatients, respectively. Among all the cyclins expressed during the S phase, cyclin D expression was the lowest in the CMLpatients. Distribution of cyclins and CDKIs during the G2/M phase was similar in the MM and control groups, whereascyclin expression was similar during all 3 phases in the MM and CML groups.
  
  
  CONCLUSIONS
  Elevated cyclin expression during cell cycle phases in the CML and MM patients was not associatedwith elevated CDKI expression. This finding may increase our understanding of the mechanisms involved in theetiopathogenesis of hematological malignancy.
authors.affiliation: Ankara University, School of Medicine Department of Hematology, Ankara, Turkey.
authors.forename: Selami K
authors.initials: SK
authors.lastname: Toprak
authors.affiliation: Ankara University, School of Medicine Department of Hematology, Ankara, Turkey.
authors.forename: Klara
authors.initials: K
authors.lastname: Dalva
authors.affiliation: Ankara University, School of Medicine Department of Hematology, Ankara, Turkey.
authors.forename: Merih Kızıl
authors.initials: MK
authors.lastname: Cakar
authors.affiliation: Ankara University, School of Medicine Department of Biostatistics, Ankara, Turkey.
authors.forename: Nazmiye
authors.initials: N
authors.lastname: Kurşun
authors.affiliation: Ankara University, School of Medicine Department of Hematology, Ankara, Turkey.
authors.forename: Meral
authors.initials: M
authors.lastname: Beksaç
keywords: Chronic myeloid leukemia; Cyclin; Cyclin dependent kinase inhibitor; Flow cytometry; Multiple myeloma
references.citation: Br J Haematol. 1999 Mar;104(3):614-7
references.pmid: 10086803
references.citation: Am J Clin Pathol. 2006 Apr;125(4):615-24
references.pmid: 16627271
references.citation: Mol Cell Biol. 1995 May;15(5):2612-24
references.pmid: 7739542
references.citation: Blood. 1997 Jul 1;90(1):279-89
references.pmid: 9207463
references.citation: Blood. 1984 Apr;63(4):789-99
references.pmid: 6584184
references.citation: Science. 1996 Dec 6;274(5293):1672-7
references.pmid: 8939849
references.citation: Cell Cycle. 2006 Mar;5(5):472-7
references.pmid: 16552186
references.citation: Nat Rev Cancer. 2009 Mar;9(3):153-66
references.pmid: 19238148
references.citation: J Clin Oncol. 2005 May 20;23(15):3412-20
references.pmid: 15809451
references.citation: Toxicol In Vitro. 2008 Sep;22(6):1503-10
references.pmid: 18586450
references.citation: Oncogene. 1995 Apr 20;10(8):1501-9
references.pmid: 7731704
references.citation: Nat Rev Cancer. 2006 May;6(5):369-81
references.pmid: 16633365
references.citation: Cancer Res. 1993 Jan 15;53(2):235-8
references.pmid: 8417814
references.citation: Cell. 1991 Sep 20;66(6):1071-4
references.pmid: 1833062
references.citation: Genes Dev. 1993 May;7(5):812-21
references.pmid: 8491378
references.citation: Semin Cell Dev Biol. 2005 Jun;16(3):311-21
references.pmid: 15840440
references.citation: Mod Pathol. 1997 May;10(5):457-62
references.pmid: 9160310
references.citation: Blood. 2004 Aug 15;104(4):1120-6
references.pmid: 15090460
references.citation: Science. 1996 Dec 6;274(5293):1659-64
references.pmid: 8939847
references.citation: Br J Haematol. 1997 Oct;99(1):131-8
references.pmid: 9359513
references.citation: Am J Clin Pathol. 2000 Jun;113(6):831-7
references.pmid: 10874884
references.citation: Biochem Biophys Res Commun. 1992 Feb 14;182(3):1144-54
references.pmid: 1531751
references.citation: Int J Clin Pract. 2004 Dec;58(12):1134-41
references.pmid: 15646411
references.citation: Blood. 1999 Mar 15;93(6):2067-74
references.pmid: 10068680
references.citation: Development. 2009 Sep;136(17):2861-72
references.pmid: 19666818
references.citation: Anticancer Res. 2004 Sep-Oct;24(5A):2991-5
references.pmid: 15517906
references.citation: Cytometry. 1997 Mar 1;27(3):250-4
references.pmid: 9041113
references.citation: Anticancer Agents Med Chem. 2008 Oct;8(7):723-31
references.pmid: 18855574
references.citation: Am J Pathol. 2000 May;156(5):1505-13
references.pmid: 10793062
references.citation: J Clin Oncol. 2005 Dec 20;23(36):9408-21
references.pmid: 16361640
references.citation: Cell Prolif. 2003 Jun;36(3):131-49
references.pmid: 12814430
references.citation: Cell Biol Toxicol. 2007 Nov;23(6):465-76
references.pmid: 17516137
references.citation: Cell Cycle. 2006 Oct;5(19):2237-43
references.pmid: 17102607
references.citation: Curr Oncol. 2009 Mar;16(2):36-43
references.pmid: 19370178
references.citation: Cell Prolif. 2003 Jun;36(3):165-75
references.pmid: 12814432
references.citation: Br J Haematol. 2000 Apr;109(1):30-8
references.pmid: 10848779
references.citation: Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Oct;13(5):751-8
references.pmid: 16277836
references.citation: Mol Genet Metab. 2006 Jul;88(3):216-24
references.pmid: 16678459
references.citation: Biochim Biophys Acta. 2010 Mar;1804(3):511-9
references.pmid: 19822225
references.citation: Cancer J. 2009 Nov-Dec;15(6):511-8
references.pmid: 20010171
references.citation: J Clin Invest. 2008 May;118(5):1750-64
references.pmid: 18431519
references.citation: Blood. 2005 Jul 1;106(1):296-303
references.pmid: 15755896
references.citation: Leuk Res. 2006 Oct;30(10):1273-8
references.pmid: 16533530
references.citation: Int J Oncol. 1998 Apr;12(4):841-6
references.pmid: 9499444
references.citation: Leukemia. 2009 Dec;23(12):2210-21
references.pmid: 19798094
references.citation: Cell Prolif. 1996 May;29(5):259-66
references.pmid: 8782488
references.citation: Curr Med Chem. 2007;14(9):969-85
references.pmid: 17439397
references.citation: Leukemia. 1998 Jun;12(6):893-8
references.pmid: 9639417
references.citation: Trends Biochem Sci. 2005 Nov;30(11):630-41
references.pmid: 16236519
references.citation: Cancer Res. 1994 Aug 15;54(16):4285-8
references.pmid: 8044772